Bio-Techne Corporation (TECH) stock analysis
TECH · Bio-Techne Corporation
Latest recorded price: USD 72.63
Model-estimated fair value: USD 16.84. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Biotechnology
At $72.63, TECH trades 331.3% above the model's base-case value of $16.84. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $13.92 in the conservative case and $20.00 in the optimistic case, with a valuation confidence score of 75/100. Fiscal 2026 figures: revenue growth 2.2%, free cash flow margin 21.7%, ROIC 9.9%. The model flags 1 risk signal for this company (1 high severity).